1-4 of 4
Kazuto Shigematsu
Close
Sort by
Journal Articles

Improved Overall Survival Among Newly Diagnosed Aggressive Adult T-Cell Leukemia/Lymphoma Patients Treated with Mogamulizumab Plus EPOCH Compared to Mogamulizumab Plus Vcap-AMP-Vecp

Tatsuro Jo, MD PhD, Kaori Matsuzaka, Haruna Shioya, Hiroo Tominaga, Takahiro Sakai, Yohei Kaneko, Shizuka Hayashi, Masatoshi Matsuo, MD, PhD, Jun Taguchi, MD PhD, Kazuto Shigematsu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4048.
https://doi.org/10.1182/blood-2019-123984
Published: 2019
Journal Articles

Skin Rash with Eosinophilia Resulting from Bendamustine Plus Rituximab Treatment: A Hematological and Pathological Analysis of 5 Cases

Tatsuro Jo, MD PhD, Kensuke Horio, MD, Kazuto Shigematsu, MD PhD, Fumi Toriyama, MD
Journal: Blood
Blood (2014) 124 (21): 5376.
https://doi.org/10.1182/blood.V124.21.5376.5376
Published: 2014
Journal Articles

Cytotoxic T-Lymphocyte Analysis of Aggressive Types of Adult T-Cell Leukemia/Lymphoma Patients with Complete Remission after Intensive Combination Chemotherapy

Tatsuro Jo, MD PhD, Kensuke Horio, MD, Kazuto Shigematsu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1648.
https://doi.org/10.1182/blood.V124.21.1648.1648
Published: 2014
Journal Articles

Extensive and destructive invasion of adult T-cell leukemia/lymphoma cells into systemic muscular tissues

Tatsuro Jo, Kazuto Shigematsu
Journal: Blood
Blood (2014) 124 (10): 1690.
https://doi.org/10.1182/blood-2014-03-561001
Published: 2014